Avanos Medical Inc
$ 11.31
-0.35%
03 Dec - close price
- Market Cap 524,998,000 USD
- Current Price $ 11.31
- High / Low $ 11.51 / 11.22
- Stock P/E N/A
- Book Value 16.76
- EPS -10.18
- Next Earning Report 2026-02-24
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.02 %
- ROE -0.47 %
- 52 Week High 19.00
- 52 Week Low 9.30
About
Avanos Medical, Inc. is a leading global medical technology company headquartered in Alpharetta, Georgia, dedicated to advancing patient care through innovative device solutions. Specializing in critical healthcare areas such as pain management and wound care, Avanos serves a diverse international market, spanning North America, Europe, the Middle East, Africa, Asia Pacific, and Latin America. With a strong emphasis on leveraging advanced technology and maintaining high-quality standards, the company plays a vital role in enhancing patient outcomes and overall quality of life worldwide.
Analyst Target Price
$14.00
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-05 | 2025-07-29 | 2025-04-30 | 2025-02-18 | 2024-10-30 | 2024-07-31 | 2024-05-02 | 2024-02-20 | 2023-11-01 | 2023-08-09 | 2023-05-03 | 2023-02-21 |
| Reported EPS | 0.22 | 0.17 | 0.1413 | 0.43 | 0.36 | 0.29 | 0.19 | 0.32 | 0.42 | 0.37 | 0.27 | 0.6 |
| Estimated EPS | 0.18 | 0.15 | 0.18 | 0.3967 | 0.35 | 0.29 | 0.21 | 0.37 | 0.28 | 0.3 | 0.27 | 0.49 |
| Surprise | 0.04 | 0.02 | -0.0387 | 0.0333 | 0.01 | 0 | -0.02 | -0.05 | 0.14 | 0.07 | 0 | 0.11 |
| Surprise Percentage | 22.2222% | 13.3333% | -21.5% | 8.3943% | 2.8571% | 0% | -9.5238% | -13.5135% | 50% | 23.3333% | 0% | 22.449% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-24 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.25 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AVNS
2025-11-02 11:35:33
Avanos Medical, Inc. released its 2024 10-K report detailing its financial performance, business operations, and strategic initiatives. The company reported a net loss of $(392.1) million driven by impairment charges, despite a 2.2% increase in net sales to $687.8 million. Avanos is undergoing a three-year transformation process, which includes divesting its Respiratory Health business and acquiring Diros Technology, Inc., to focus on core markets like Digestive Health and Pain Management and Recovery.
2025-10-23 12:00:00
WRS Group has entered into a definitive agreement to acquire substantially all assets and rights related to Avanos Medical's US Game Ready® orthopedic rental business. This acquisition strengthens WRS's position in the US orthopedic market and enhances its ability to provide recovery solutions. Avanos Medical will continue to manufacture and supply Game Ready systems, focusing on its core growth platforms.
2025-10-16 23:06:35
Dimensional Fund Advisors LP reduced its stake in Avanos Medical Inc. by 8.74%, selling 225,430 shares, though Avanos Medical still accounts for a minor portion of the firm's portfolio. Avanos Medical, a medical device company, is noted for its mixed financial performance, including a significantly negative EBITDA growth and a stock price below its GF Value, indicating a potential value trap.
2025-10-16 17:50:03
This article analyzes Avanos Medical Inc. (NASDAQ: AVNS) using AI models, indicating weak sentiment across all time horizons and supporting a short bias. It highlights a significant risk-reward short setup with a 14.0% downside target against a minimal risk. The article also presents institutional trading strategies, including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis.
2025-10-15 20:11:00
A recent Lobbying Disclosure Act filing revealed that AVANOS MEDICAL INC. (fka HALYARD HEALTH INC.) disclosed $60,000 in lobbying expenses for Q3 2025, addressing issues like proposed tariffs. The article also details insider trading activity, showing Gary Blackford's two purchases of 60,000 shares for an estimated $659,300, and significant hedge fund activity with 126 institutions adding and 99 decreasing their positions in AVNS stock.
2025-07-24 10:20:00
Avanos Medical (NYSE: AVNS) has scheduled its Q2 2025 earnings conference call for August 5, 2025, at 9 a.m. ET. The company will release its financial results before the market opens on the same day. The call will be hosted by CEO Dave Pacitti, interim CFO Jason Pickett, and SVP of Strategy Scott Galovan, with webcast and replay options available for investors.
